Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London

Core Viewpoint - Whitehawk Therapeutics, Inc. is set to present at the Jefferies Global Healthcare Conference, highlighting its focus on advanced oncology therapeutics and antibody drug conjugate (ADC) cancer treatments [1][2]. Company Overview - Whitehawk Therapeutics specializes in oncology therapeutics, utilizing advanced technologies to enhance established tumor biology for improved cancer treatment delivery [3]. - The company has developed a three-asset ADC portfolio designed to address the limitations of first-generation ADCs, aiming to significantly benefit patients with challenging cancers [3]. - These ADC assets are exclusively licensed from WuXi Biologics, covering development and global commercialization [3].